COMPANY PROFILE

YuceBio / 裕策生物

Explore full profile

Shenzhen immuno-oncology NGS and biomarker diagnostics OEM

Shenzhen, ChinaFounded 2015Biotech & Life Sciences

Valuation $50–100M Last recorded · 2021

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About YuceBio / 裕策生物

YuceBio / 裕策生物 (Shenzhen Yuce Biotechnology) is a Shenzhen tumor-immunotherapy diagnostics and NGS OEM founded in 2015. The company builds immuno-oncology biomarker panels and comprehensive solutions for research and clinical precision oncology, including neoantigen prediction (TruNeo) and multi-gene assays (YuceOne) for hospitals and pharma CDx / trial support. Mid-size China NGS leftover beyond Basecare and Burning Rock FIX and Pack 39 AmoyDx and iGeneTech FIX — city-level Shenzhen HQ, conservative employees band 51-200 given directory vs insured conflict.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Shenzhen, China
Employees: 37
Open positions: None listed
Dealroom signal: 26.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Nov 2021	$14M	$55M	Tzitzit Aseet	↗
SERIES COther financing	Aug 2020	$43M	$172M	Undisclosed	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

YuceBio / 裕策生物 website traffic

Latest recorded traffic for YuceBio / 裕策生物 is 40 monthly website visits, down 90% over the last three months. YuceBio / 裕策生物's team grew 0% over the past year.

Latest monthly visits40 3-month web change-90% 1-year team growth0%

Monthly website visitsAug 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ENEnvoyaPolymer-Based Nanoparticles for Targeted delivery	Boston, United States	Operational	10	$2M	$8M
TGTongshu GeneA high-tech enterprise that focuses on scientific and technological innovation and focuses on precise molecular diagnosis of tumors	China	Operational
MIMicroMGxThe MGx platform technology, discovers new chemistry by harnessing the power of microbes	Chicago, United States	Operational
BPBio PaletteBio Palette aims to become a world-leading company in the field of microbiome therapeutics by using bacteria optimized by genome editing to modify and control microbiomes	Kobe, Japan	Operational
BIBiospinA biotechnology company developing solutions to protect people from pathogens	Singapore, Singapore	Operational
AVAvantGuardAvantGuard (formerly Halomine) manufactures and supplies high-performance and human-friendly antimicrobial coating materials and technology	Ithaca, United States	Operational
ACActXFocused on making patient genomic information that are useful in everyday medical practice	Seattle, United States	Operational
BIBillionToOneThe only genetic testing platform that accurately and efficiently detects and measures disease at the molecular level	Menlo Park, United States	Operational